Predictive value of immunohistochemical thymidylate synthase expression for histological response to tegafur/uracil (UFT) in oral squamous cell carcinoma

International Journal of Oral and Maxillofacial Surgery

Volumn 32, Issue 6, 2003, Pages 633-637

  Kawano, Kenji ^a   Goto, H ^a   Kanda, T ^a   Yanagisawa, S ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Chemosensitivity; Histological response; Oral squamous cell carcinoma; Thymidylate synthase; UFT

Indexed keywords

DRUG METABOLITE; FLOXURIDINE PHOSPHATE; FLUOROPYRIMIDINE; FLUOROURACIL; TEGAFUR; THYMIDYLATE SYNTHASE; UFT;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CELL DEATH; CELL DEGENERATION; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA SYNTHESIS; DRUG RESPONSE; DRUG TARGETING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PREDICTION; PREOPERATIVE TREATMENT; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY;

EID: 0344466360     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1054/ijom.2002.0411     Document Type: Article

References (19)

1. Beck A, Etienne MC, Cheradame S, Fischel JL, Formento P, Renee N, Milano G. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur J Cancer 1994: 30A: 1517-1522.
2. Boeheim K, Spoendlin H. The effect of chemotherapy in relation to pathohistological tumour grading in head and neck cancer. Arch Oto-rhino-laryngol 1983: 238: 197-204.
3. Cheradame S, Etienne MC, Formento P, Schneider M, Dassonville O, Demard F, Milano G. Tumoral-reduced folates and clinical resistance to fluorouracil-based treatment in head and neck cancer patients. J Clin Oncol 1997: 15: 2604-2610.
4. Chu E, Koeller DM, Johnston PG, Zinn S, Allegea CJ. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. Mol Pharmacol 1993: 43: 527-533.
5. Jakobsson PA, Eneroth C-M, Killander D, Moberger G, Martensson B. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol 1973: 12: 1-8.
6. Johnston PG, Drake JC, Trepel J, Allegra CJ. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fliorouracil-sensitive and -resistant human cancer cell lines. Cancer Res 1992: 52: 4306-4312.
7. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA, Allegra CJ. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994: 12: 2607-2640.
8. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995: 55: 1407-1412.
9. Johnston PG, Mick R, Recant W, Behan KA, Dolan ME, Ratain MJ, Beckmann E, Weichselbaum RR, Allegra CJ, Vokes EE. Thymidylate synthase expression and response to neo-adjuvant chemotherapy in patients with advanced head and neck cancer. J Natl Cancer Inst 1997: 89: 308-313.
10. Kaku Y, Kawano K, Shimuzu M. Immunoreactive tenascin and fibronectin in oral squamous cell carcinomas: Distribution changes in the repair process after preoperative therapy. Asian J Oral Maxillofac Surg 1996: 8: 35-47.
11. Lenz HJ, Leichman CG, Danenberg KD, Danenberg PV, Groshen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Garcia Y, Li J, Leichman L. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol 1996: 14: 176-182.
12. Moran RG, Spears CP, Heidelberger C. Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultra-sensitive methods for the determination of 5-fluoro-2′-deoxyuridinylate, 2′-deoxyuridylate, and thymidylate synthetase. Proc Natl Acad Sci USA 1979: 76: 1456-1460.
13. Naguib FN, El Kouni MH, Cha S. Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 1985: 45: 5405-5412.
14. Nakano H, Namatame K, Suzuki T, Takahashi H, Sakai H, Nakamura T, Kumada K. Histopathological response to preoperative chemotherapy including 5-fluorouracil additionally assessed by immunocytochemical and pharmacologic parameters in patients with advanced gastric cancer. Surg Today 1996: 26: 482-488.
15. Pindborg JJ, Reichart PA, Smith CJ, Van Der Waal I. Squamous Cell carcinoma. In: Histological Typing of Cancer and Precancer of the Oral Mucosa. International Histological Classification of Tumours, 2nd ed., World Health Organization. Berlin: Springer-Verlag 1997: 11-13.
16. Santi DV, McHenry CS, Sommer H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 1974: 13: 471-481.
17. Shiga H, Heath EI, Rasmussen AA, Trock B, Johnston PG, Forastiere AA, Langmacher M, Baylor A, Lee M, Cullen KJ. Prognostic value of p53, glutathione S-transferaseπ, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res 1999: 5: 4097-4104.
18. Yamaoka H, Tsukuda M, Mochimatsu I, Nagahara T, Enomoto H, Kagata H, Kagesato Y, Daicho S, Mizuno H, Nishimura G, Baba Y, Kawakami K. Thymidylate synthase expression in patients with hypopharyngeal carcinoma. Jpn J Cancer Chemother 1998: 25: 1007-1012 (in Japanese).
19. Yeh K-H, Shun C-T, Chen C-L, Lin J-T, Lee W-J, Lee P-H, Chen Y-C, Cheng A-L. High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy. Cancer 1998: 82: 1626-1631.